In 2001, having completed his training in Gynaecology and Obstetrics in Austria, Martin worked at the Norris Comprehensive Cancer Centre in Los Angeles (USA) on translational epigenetics (Prof Peter A Jones group) and spent three years as the lead clinician and surgeon of a large breast cancer centre before embarking on a career at UCL/UCLH from 2005 where he undertook sub-speciality training in gynaecological oncology. As the Head of Department of Women’s Cancer within the UCL EGA Institute for Women’s Health, he established a research group focusing on the role of early detection, risk prediction, and prevention of breast and gynaecological cancers within several major research programmes (EpiFemCare, FORECEE, BRCA PROTECT and BRCA PREVENT). In 2016, Martin was awarded a Fellowship ad eundem of the Royal College of Obstetrics and Gynaecology (FRCOG) and since March 2020, he has been Professor for Cancer Prevention and Screening, as well as the Director of the European Translational Oncology Prevention & Screening (EUTOPS) Institute at the Leopold-Franzens-University of Innsbruck, Austria. In July 2020, Martin was conferred a Guest Professorship at the Karolinska Institutet, Stockholm, Sweden.
Prof Martin Widschwendter was the PI and Coordinator of several EU projects including the 7th Framework Programme (FP7), Horizon 2020 (H2020), and was also awarded a European Research Council (ERC) Advanced Grant.
